Additional file 6: of Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

List of independent ethics committees or institutional review boards. Complete list of independent ethics committees for all sites that screened subjects for the ApoE ε4 noncarrier study. (PDF 339 kb)